NCT02062905View on ClinicalTrials.gov

OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

November 30, 2014

Conditions
Chronic Allergic Conjunctivitis
Interventions
DRUG

Dexamethasone

OTHER

Placebo Vehicle

Sponsors
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Ocular Therapeutix, Inc.

INDUSTRY